I have been running GHK-Cu for three years and the honest summary is that the effect is smaller than the internet suggests and real.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
Where does the human data stop and the extrapolation start?
Stupid question: how do you know whether what is in the vial matches the label at all?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.